198 related articles for article (PubMed ID: 21094234)
1. Release behaviour of clozapine matrix pellets based on percolation theory.
Aguilar-de-Leyva A; Sharkawi T; Bataille B; Baylac G; Caraballo I
Int J Pharm; 2011 Feb; 404(1-2):133-41. PubMed ID: 21094234
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
Miranda A; Millán M; Caraballo I
J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
[TBL] [Abstract][Full Text] [Related]
3. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
Ige PP; Gattani SG
Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
[TBL] [Abstract][Full Text] [Related]
4. Study of the critical points of experimental HPMC-NaCMC hydrophilic matrices.
Contreras L; Melgoza LM; Villalobos R; Caraballo I
Int J Pharm; 2010 Feb; 386(1-2):52-60. PubMed ID: 19900524
[TBL] [Abstract][Full Text] [Related]
5. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
6. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
7. Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique.
He H; Shi B; Cai C; Tang X
Arch Pharm Res; 2011 Nov; 34(11):1931-8. PubMed ID: 22139692
[TBL] [Abstract][Full Text] [Related]
8. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
Miranda A; Millán M; Caraballo I
Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
[TBL] [Abstract][Full Text] [Related]
9. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
Fuertes I; Miranda A; Millán M; Caraballo I
Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
[TBL] [Abstract][Full Text] [Related]
10. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
11. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
[TBL] [Abstract][Full Text] [Related]
13. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
[TBL] [Abstract][Full Text] [Related]
14. The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets.
Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2015 Jan; 41(1):70-8. PubMed ID: 24134563
[TBL] [Abstract][Full Text] [Related]
15. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
16. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
[TBL] [Abstract][Full Text] [Related]
17. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
18. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
Mitchell SA; Balwinski KM
J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
[TBL] [Abstract][Full Text] [Related]
19. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
[TBL] [Abstract][Full Text] [Related]
20. Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties.
Cifuentes C; Aguilar-de-Leyva A; Rajabi-Siahboomi AR; Caraballo I
Acta Pharm; 2013 Mar; 63(1):115-29. PubMed ID: 23482317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]